AgingResearch.News
Cureus

Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review

By Zakariya Y Alsanosi, Ali A Alshahrani, Abdulaziz Abdullah Nammazi, Show 7 more authorsAljoudi A Almajdoa
Figure 1. PRISMA flow diagram depicting the study selection process for the systematic review.
Open the figure at full size
Figure 1. PRISMA flow diagram depicting the study selection process for the systematic review.PRISMA flow diagram depicting the study selection process for the systematic review.Alsanosi et al.
Systematic review of randomised trialsInterventions

333 participants randomized, declared no competing interests

Paper

The paper

Zakariya Y Alsanosi, Ali A Alshahrani, Abdulaziz Abdullah Nammazi, Show 7 more authorsAljoudi A Almajdoa

Eradah Hospital; Batterjee Medical College

Cureus, 11 Aug 2026

doi.org/10.7759/cureus.114350PubMed 42725235

More on GLP-1 receptor agonists